MedPath

BACLOFEN

Baclofen Oral Solution These highlights do not include all the information needed to use Baclofen Oral Solution safely and effectively. See full prescribing information for Baclofen Oral Solution. Baclofen Oral Solution Initial U.S. Approval: 1977

Approved
Approval ID

6cc2773b-cb64-48e9-a69b-e457b82cb2d4

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 28, 2022

Manufacturers
FDA

Palmetto Pharmaceuticals Inc.

DUNS: 963291864

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Baclofen

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68134-401
Application NumberNDA208193
Product Classification
M
Marketing Category
C73605
G
Generic Name
Baclofen
Product Specifications
Route of AdministrationORAL
Effective DateMarch 28, 2022
FDA Product Classification

INGREDIENTS (8)

TRISODIUM CITRATE DIHYDRATEInactive
Code: B22547B95K
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
PROPYLPARABENInactive
Code: Z8IX2SC1OH
Classification: IACT
SUCRALOSEInactive
Code: 96K6UQ3ZD4
Classification: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
BACLOFENActive
Quantity: 5 mg in 5 mL
Code: H789N3FKE8
Classification: ACTIB
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BACLOFEN - FDA Drug Approval Details